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The cardiomyogenic potential of adult bone marrow 
(BM) cells after being directly transplanted into the isch-
emically injured heart remains a controversial issue. In 
this study, we investigated the ability of transplanted 
BM cells to develop intracellular calcium ([Ca2+]i) tran-
sients in response to membrane depolarization in situ. 
Low-density mononuclear (LDM) BM cells, c-kit-enriched 
(c-kitenr) BM cells, and highly enriched lin– c-kit+ BM cells 
were obtained from adult transgenic mice ubiquitously 
expressing enhanced green fluorescent protein (EGFP), 
and injected into peri-infarct myocardiums of nontrans-
genic mice. After 9–10 days the mice were killed, and 
the hearts were removed, perfused in Langendorff mode, 
loaded with the calcium-sensitive fluorophore rhod-2, 
and subjected to two-photon laser scanning fluorescence 
microscopy (TPLSM) to monitor action potential–induced 
[Ca2+]i transients in EGFP-expressing donor-derived cells 
and non-expressing host cardiomyocytes. Whereas spon-
taneous and electrically evoked [Ca2+]i transients were 
found to occur synchronously in host cardiomyocytes 
along the graft–host border and in areas remote from 
the infarct, they were absent in all of the >3,000 imaged 
BM-derived cells that were located in clusters through-
out the infarct scar or peri-infarct zone. We conclude that 
engrafted BM-derived cells lack attributes of functioning 
cardiomyocytes, calling into question the concept that 
adult BM cells can give rise to substantive cardiomyocyte 
regeneration within the infarcted heart.
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IntroductIon
Conflicting data exist as to the ability of adult bone marrow (BM) 
cells to give rise to cardiomyocytes within the injured heart.1 The 
possibility of cardiomyocyte formation by adult BM-derived stem 
cells was initially demonstrated in a study by Bittner et al.,2 who 
observed dystrophin-expressing cardiomyocytes in mdx mice 
after BM reconstitution with wild-type donor cells. Subsequently, 
Jackson et al.3 induced myocardial ischemia/reperfusion injury 
in mice after BM reconstitution with so-called side population 
cells that were genetically engineered to express β-galactosidase. 
Donor cell–derived cardiomyocytes were detected in the peri-
infarct zone, albeit at a very low prevalence (0.02%). A study by 
Xaymardan et al.4 showed that a small percentage of fluorescently 
labeled unfractionated BM cells obtained from adult rats can 
acquire a cardiomyocyte phenotype in an infarct transplantation 
model. Similarly, fluorescently tagged BM mononuclear cells from 
patients with previous myocardial infarction were shown to trans-
differentiate into cardiomyocytes when seeded on cryoinjured 
mouse ventricles in culture.5
A limited number of studies have reported extensive myo-
cardial regeneration from BM-derived cells within the infarcted 
heart.6,7 In these latter studies, female mice were subjected to 
permanent coronary artery ligation, and c-kit-positive BM 
cells from adult male transgenic mice ubiquitously express-
ing enhanced green fluorescent protein (EGFP) were directly 
injected into the viable peri-infarct region. De novo formation of 
donor cell–derived cardiomyocytes was assessed by co-staining 
for cardiomyocyte-specific markers plus Y chromosome or EGFP. 
By this approach, it was demonstrated that transplanted BM cells 
could give rise to millions of new cardiomyocytes by 9 days after 
intracardiac injection, resulting in partial replacement of the scar 
with functioning muscle. The concomitant improvement of left 
ventricular contractility led the authors to suggest that de novo 
cardiomyocytes became electromechanically integrated and were 
thus capable of directly contributing to the overall pump function 
of the injured heart.
Numerous other studies have failed to observe cardiomyo-
genic differentiation from adult BM-derived donor cells. For 
example, Balsam et al.8 demonstrated that purified popula-
tions of adult hematopoetic stem cells obtained from transgenic 
mice widely expressing EGFP transiently engrafted within the 
infarcted myocardium, but did not express cardiac tissue–specific 
markers. Rather, most of the donor-derived cells expressed the 
pan-hematopoetic marker CD45 and the myeloid marker Gr-1. 
Nygren et al.9 did not observe cardiomyogenic transformation of 
unfractionated BM cells or c-kit+-enriched hematopoetic stem 
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cells after engraftment within the infarcted mouse myocardium, 
as evidenced by the absence of cardiomyocyte-specific immune 
reactivity in the donor cells. Murry et al.10 utilized cardiomyocyte-
restricted transgenes (expressing either β-galactosidase or EGFP 
under the regulation of the α-cardiac myosin heavy chain promoter) 
as well as a ubiquitously expressed EGFP reporter transgene (in 
conjunction with histochemical analyses) to track the fate of two 
purified populations of BM-derived hematopoetic stem cells (lin– 
c-kit+ and lin– c-kit+ sca-1+ cells) after their transplantation 
into injured hearts. Although donor cells did engraft in the dam-
aged muscle, no transdifferentiation events were detected, as evi-
denced by the lack of expression of a cardiomyocyte-restricted 
reporter transgene, as well as the absence of cardiomyocyte-
 specific immune reactivity in the donor cells.10
When all these findings are considered collectively, the ques-
tion of whether regeneration of cardiomyocytes can be achieved 
by engrafting adult BM-derived cells within the injured heart 
remains highly controversial, despite the use of seemingly iden-
tical donor cells and experimental conditions in various studies. 
In this study, we elected to use an assay that relied on examina-
tion of function rather than of potentially subjective immune 
histologic endpoints, to examine the regenerative potential of 
adult BM-derived cells in the infarcted heart. Specifically, we 
systematically probed the ability of engrafted BM-derived cells 
to develop intracellular calcium ([Ca2+]i) transients in response 
to membrane depolarization within the intact heart, using a 
previously developed two-photon laser scanning microscopy 
(TPLSM)-based imaging technique.11,12 A side-by-side com-
parison was performed, of low-density mononuclear (LDM) 
BM cells, c-kit-enriched (c-kitenr) BM cells, and highly enriched 
hematopoetic stem cells (lin– c-kit+ BM cells), obtained from 
adult transgenic mice ubiquitously expressing EGFP. We dem-
onstrate that all donor cell types were efficiently engrafted in the 
infarcted tissue of nontransgenic recipient hearts at day 9 after 
the cell injection. However, while spontaneous and electrical 
stimulation–induced [Ca2+]i transients were observed to occur 
synchronously in host cardiomyocytes along the graft–host bor-
der, they were absent in all of the >3,000 imaged BM-derived 
cells that were located in clusters within the infarct scar or bor-
der zone. These results indicate that engrafted BM-derived cells 
lack fundamental attributes of functioning cardiomyocytes, and 
further call into question the concept that adult BM cells can 




ACT-EGFP mice were used for isolating donor BM cells. These 
mice express EGFP under the control of the chicken β-actin pro-
moter.13 In control experiments, a comparison of 10-μm sections 
obtained from adult ACT-EGFP and wild-type mouse hearts 
under epifluorescence illumination demonstrated that all cardio-
myocytes in the transgenic hearts expressed EGFP throughout 
the cytoplasm and nuclei (Figure 1). The kinetics of electrically 
evoked [Ca2+]i transients in adult ACT-EGFP hearts were indistin-
guishable from those in wild-type hearts (data not shown). From 
these observations, we expect any BM-derived cardiomyocytes 
from ACT-EGFP mice to express EGFP stably, and to function 
normally.
Three different donor BM cell populations were studied, 
namely, LDM BM cells, c-kit-enriched (c-kitenr) BM cells, and 
highly enriched lineage negative (lin–) c-kit+ BM cells. LDM 
BM cells were isolated using a density centrifugation protocol as 
published earlier.9 c-kitenr BM cells were isolated using magnet-
activated cell sorting. Flow cytometry analyses of the c-kitenr BM 
cells demonstrated that the percentage of c-kit-positive cells in 
the eluted (i.e., labeled) fraction from the magnetic column was 
approximately fivefold to sixfold larger than that in the eluent 
(i.e., unlabeled) fraction (Figure 2a). The c-kitenr BM cell popula-
tion was further assayed for the expression of EGFP and a vari-
ety of surface antigens. Before enrichment, 35% (dotted area in 
Figure 2b) of the cells in the initial LDM BM preparation were 
EGFP positive (Figure 2c). We confirmed the percentage of 
EGFP-expressing cells using additional epifluorescence analyses. 
Our number is in good agreement with earlier studies that used 
EGFP reporter transgenes to track the cardiomyogenic potential 
of marrow-derived cells.7,14 c-kitenr BM cells were 45% negative for 
a cocktail of antibodies that recognize mature hematopoetic cells, 
including lymphocytes, monocytes, granulocytes, neutrophils, and 
erythrocytes (Figure 2d). Markers for hematopoetic stem and pro-
genitor cells (CD34, sca-1, flk-1) were present in 4% (flk-1) to 21% 
(sca-1) of the c-kitenr BM cell population (Figure 2e–g). Restricting 
the flow cytometry analysis to the subfraction of EGFP-positive 
cells within the c-kitenr BM cell population did not alter the expres-
sion profile of surface antigens (see Supplementary Figure S1), 
thereby suggesting that the presence of the fluorescent protein 
does not impart negative or positive selections on BM subpopula-
tions. Highly enriched lin– c-kit+ BM cells were prepared by first 
removing cells expressing hematopoetic lineage markers through 
magnetic immunobead subtraction.15 This lin– fraction was then 
reacted with an anti-c-kit monoclonal antibody and separated 
using fluorescence-activated cell sorting into c-kit+ and c-kit– cells 
(Figure 2h). Lin– cells that showed c-kit expression levels 2-fold to 
100-fold higher than EGFP–/c-kit– cells were used for intracardiac 
transplantation (only EGFP-expressing cells were used).
ACT-EGFP BM-derived cells stably engraft  
infarcted myocardium
The peri-infarct regions of nontransgenic hearts were injected 
with 100,000 LDM, c-kitenr, or lin– c-kit+ BM cells. The mice were 
TG NTG
Figure 1 representative epifluorescence images of 10-μm sections 
obtained from the hearts of an adult ACT-EGFP transgenic (tG) 
mouse and its nontransgenic (ntG) adult littermate. Sections were 
stained with Hoechst. Images for EGFP (green) and Hoechst (blue) fluo-
rescence were merged. The imaging parameters were identical for both 
sections. EGFP, enhanced green fluorescent protein.
© The American Society of Gene Therapy
Bone Marrow Cells for Myocardial Repair
Molecular Therapy  vol. 16 no. 6 june 2008 1131
subsequently killed and the hearts were removed and processed to 
monitor scar formation and donor cell viability, using sirius red/
fast green histochemical staining and a chromogenic anti-EGFP 
immune reactivity assay, respectively. The analysis was performed 
at 9 to 10 days after the engraftment, because earlier studies had 
suggested that extensive cardiomyocyte regeneration from lin– c-
kit+ BM cells takes place within this period.6,7,16 Figure 3 shows 
representative examples of grafts generated with each cell type. In 
accordance with earlier observations,6–10,16 we found high levels 
of EGFP+ cells that were primarily located in clusters throughout 
the infarcted tissue and in the bordering peri-infarct zone rather 
than in the viable myocardium. The analysis showed that all three 
BM-derived donor cell types survived and efficiently engrafted 
the infarcted myocardium.
It had been reported earlier that green autofluorescence can 
be mistaken for EGFP fluorescence in the ischemically injured 
heart under epifluorescence illumination.17 TPLSM imaging of 
peri-infarct regions in Langendorff-perfused mouse hearts simi-
larly revealed strongly autofluorescent structures. They could 
however be reliably distinguished from EGFP fluorescence on 
the basis of their distinct emission profiles under the vital imag-
ing conditions used in this study (for details, see Supplementary 
Data S1 and Supplementary Figure S2).
engrafted donor-derived cells lack electrically evoked 
[ca2+]i transients
We next investigated the functional fate of ACT-EGFP BM-derived 
cells after transplantation into peri-infarct regions. The hearts that 
had received LDM BM cells were examined first. The mice were 
killed 9 or 10 days after the BM cell injection, and the hearts were 
removed, loaded with rhod-2 (a calcium-sensitive fluorescent dye), 
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Figure 2 Analysis of c-kitenr (panels a–g) and highly enriched lin– c-kit+ (panel h) bone marrow (BM) cells. (a) Representative flow cytometry 
dot plots of the eluted (positively labeled; right panel) and eluent (unlabeled; middle panel) fractions of c-kitenr BM cells based on levels of enhanced 
green fluorescent protein (EGFP) (x-axis) and c-kit (y-axis) expressions. The left panel shows isotype control. The axes are log-scaled. (b–g) Flow 
cytometry analyses of surface antigen expression in ACT-EGFP c-kitenr BM cells. c-kitenr BM cells were selected for c-kit+ (CD117+) cells using magnet-
activated cell sorting as described in Materials and Methods. (b) Light scatter gating of eluted cells identified ~70% of the cells within the low-density 
mononuclear gate (FSC, forward scatter). (c) Analysis of GFP expression versus side scatter (SSC) identified 35% of eluted cells as GFP+. (d) Expression 
of lineage markers (x-axis) versus c-kit expression (y-axis) among cells falling within the mononuclear gate as defined in b. (e) Expression of CD34 
(x-axis) versus c-kit expression (y-axis) among cells falling within the lymphocyte gate. (f) Expression of Sca-1 (x-axis) versus c-kit expression (y-axis) 
among cells falling within the mononuclear gate. (g) Expression of Flk-1 (x-axis) versus c-kit expression (y-axis) among cells falling within the mono-
nuclear gate. (h) Fluorescence-activated cell sorting (FACS) of ACT-EGFP, lineage-depleted (lin–) mouse BM cells based on c-kit and EGFP expression. 
Representative FACS dot plot of lin– BM cells stained with ACK-4/Biotin/streptavidin–phycoerythrin (streptavidin–PE). Antibody-labeled cells were 
separated using FACS into four subsets based on the number of c-kit receptors (y-axis) and levels of EGFP (x-axis) expression. The box in upper right 
rectangle indicates the fraction of c-kit+/EGFP+ cells that was used for cell transplantation (lin– c-kit+ group). The mean expression levels of both c-kit 
and EGFP in c-kit+/EGFP+ cells were ~2-fold to ~100-fold higher than those in c-kit–/EGFP– cells (lower left rectangle).
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along the graft–host border, with the presence of [Ca2+]i transients 
in host cardiomyocytes within the same microscopic field provid-
ing a good positive control. A representative frame-mode image 
obtained during remote point stimulation at 4 Hz is shown in 
Figure 4a. A cluster of small (<10 μm diameter), round, donor-
derived cells, readily identifiable by virtue of their EGFP fluores-
cence, were present adjacent to the peri-infarct border zone of the 
host myocardium. The host cardiomyocytes located on either side 
of the BM cell graft exhibited periodic increases in rhod-2 fluores-
cence (denoted by asterisks), reflecting cyclic increases in intracel-
lular free calcium triggered by propagated action potentials. The 
calcium responses in these cells appear to be in synchrony and at 
the same frequency as remote stimulation, indicating that they are 
functionally coupled to the remote myocardium outside the peri-
infarct region. In contrast, no [Ca2+]i transients were detectable in 
the cluster of EGFP-expressing donor-derived cells.
We also obtained line-scan images from the graft–host bor-
der by repeatedly scanning at a high rate (500 Hz) along the white 
line in Figure 4a during remote electrical stimulation at 4 Hz. 
The scan line traversed a host cardiomyocyte, a juxtaposed cap-
illary, and a small donor-derived cell. The line scans were then 
stacked such that the y-axis represents time and the x-axis rep-
resents distance (Figure 4b). Spatially averaged traces for the red 
and green fluorescence signals were then generated from the line-
scan data (Figure 4c). These traces confirm the presence of action 
 potential–evoked calcium responses in the host cardiomyocytes, 
and the absence of calcium responses in the neighboring LDM 
BM-derived cells. A series of x, y scans taken at 4-μm z-steps 
along the graft–host border during continuous electrical point 
stimulation at 4 Hz similarly did not reveal calcium responses in 
the cluster of donor-derived cells (Figure 4d).
LDM
Sirius red/fast green Anti-GFP
c-kitenr
lin− c-kit+
Figure 3 direct transplantation and engraftment of ACT-EGFP bone 
marrow (BM) cells into infarcted myocardium of nontransgenic 
recipients. Left panels: Sirius red– and fast green–stained histological 
sections from infarcted hearts at 9 days after left coronary artery ligation 
and transplantation of 100,000 ACT-EGFP BM cells. Right panels: adjacent 
sections from the same hearts immunostained for EGFP (brown signal, 
horseradish peroxidase–conjugated secondary antibody, signal devel-
oped with diaminobenzidine reaction). Scale bar: 30 μm. EGFP, enhanced 























Figure 4 simultaneous imaging of rhod-2 and enhanced green 
fluorescent protein (eGFP) fluorescence in a nontransgenic heart 
at 9 days after coronary artery ligation and injection of ACT-EGFP 
low-density mononuclear bone marrow cells into the peri-infarct 
zone. (a) Full-frame two-photon laser scanning fluorescence micros-
copy (TPLSM) image of the graft–host myocardium border zone. The 
hearts were loaded with rhod-2. Red (rhod-2) and green (EGFP) fluo-
rescence signals were superimposed. Host cardiomyocytes and donor-
derived cells (green/yellow) are apparent. The preparation was paced by 
point stimulation at a remote site at 4 Hz. The white bar demarcates the 
position of line-scan mode data acquisition. Asterisks denote host cardio-
myocytes with [Ca2+]i transients. Scale bar: 20 μm. (b) Stacked line-scan 
images of the regions in a demarcated by the blue dotted lines. The 
line-scans traverse one non-EGFP-expressing (host) cardiomyocyte and 
one EGFP-expressing (donor derived) cell. Scale bars: 20 μm horizontally, 
125 ms vertically. (c) Spatially integrated changes in rhod-2 and EGFP 
fluorescence for one host cardiomyocyte and one juxtaposed donor-
derived cell. The fluorescence signal across the entire cell was averaged. 
(d) Full-frame TPLSM images obtained from the heart depicted in a at 
increasing depths. The heart was paced by point stimulation at a remote 
site at 4 Hz. The numbers indicate nominal distance of the focal plane 
from the epicardial surface. Scale bar: 20 μm. 
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In order to exclude the possibility that the absence of sponta-
neous and remote stimulation-evoked [Ca2+]i transients in donor-
derived cells results from a lack of electrical coupling between 
donor and host cells (rather than from an intrinsic inability to 
raise cytosolic calcium in response to membrane depolarization), 
we also monitored changes in [Ca2+]i during electrical field stim-
ulation (100 V, 2 ms, 3 Hz). Under these conditions, the develop-
ment of [Ca2+]i transients is no longer dependent on intercellular 
action potential propagation. Electrical field stimulation readily 
evoked [Ca2+]i transients in host cardiomyocytes at sites remote 
from the graft as well as in areas bordering donor cell clusters, 
but not in donor-derived cells within the clusters. Collectively, 
these data indicate that engrafted LDM BM-derived cells within 
the infarcted tissue lack the ability to raise cytosolic calcium tran-
siently in response to electrical membrane excitation. Similarly, 
no [Ca2+]i transients were inducible in BM-derived cell clusters in 
the center of the scar during spontaneous sinus rhythm, remote 
electrical point stimulation, or electrical field stimulation. A total 
of >300 LDM BM-derived cells, imaged and distributed among 
eight animals, were shown to lack spontaneous or electrically 
evoked [Ca2+]i transients.
We next examined the functional fate of c-kitenr and lin– 
c-kit+ BM cells following their direct injection into peri-
infarct regions. Representative TPLSM images obtained from 
hearts 9 days after the transplantation of either donor cell 
type are shown Figures 5 and 6. Frame-mode and line-scan 
mode images revealed synchronous and periodic increases in 
rhod-2 fluorescence in host cardiomyocytes at the graft–host 
border during electrical point stimulation at 4 Hz, but not in 
donor-derived cell clusters which, in many cases, appeared to 
be in physical contact with functioning host myocytes (see in 
Figures 5a and 6a). Line scan data (Figures 5b and 6b) were 
used for generating spatially averaged traces for the green and 
red fluorescent signals (Figures 5c and 6c), which confirmed the 
presence of action potential-evoked [Ca2+]i transients in host 
cardiomyocytes, and the absence of such transients in donor-
derived cells, respectively. Electrical field stimulation also failed 
to evoke cytosolic calcium transients in these donor-derived cell 
populations. Moreover, we did not detect spontaneous or elec-
trically evoked calcium responses in donor-derived cells located 
within the infarct scar remote from functioning host cardio-
myocytes. Identical results were obtained in a total of >1,700 
and >1,300 donor-derived cells after transplantation of c-kitenr 
and lin– kit+ BM cells, respectively. These cells were distributed 
among 10 animals per group. Therefore, our results indicate that 
the clustered EGFP-expressing cells, whether they are derived 
from LDM, c-kitenr, or lin– c-kit+ BM cells, lack the ability to 
develop cytosolic calcium transients in response to membrane 
depolarization, and consequently do not function as cardiomy-
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Figure 5 simultaneous imaging of rhod-2 and enhanced green flu-
orescent protein (eGFP) fluorescence in a nontransgenic heart at 
9 days following coronary artery ligation and injection of ACT-EGFP 
c-kitenr bone marrow cells into the peri-infarct zone. (a) Full-frame 
two-photon laser scanning fluorescence microscopy image of the graft–
host myocardium border zone. The hearts were loaded with rhod-2. Host 
cardiomyocytes (red) and donor-derived cells (green/yellow) are appar-
ent. The preparation was paced by point stimulation at a remote site 
at 4 Hz. The white bar demarcates the position of line-scan mode data 
acquisition. Scale bar: 20 μm. (b) Stacked line-scan images of the regions 
in a demarcated by the blue dotted lines. The line-scans traverse two 
non-EGFP-expressing (host) cardiomyocytes and three EGFP-expressing 
(donor derived) cells. Scale bars: 20 μm horizontally, 125 ms vertically. 
(c) Spatially integrated changes in rhod-2 and EGFP fluorescence for one 
host cardiomyocyte and one juxtaposed donor-derived cell. The fluo-

















Figure 6 simultaneous imaging of rhod-2 and enhanced green 
 fluorescent protein (eGFP) fluorescence in a nontransgenic heart 
at 9 days after coronary artery ligation and injection of ACT-EGFP 
lin– c-kit+ bone marrow (BM) cells into the peri-infarct zone. 
(a) Full-frame two-photon laser scanning fluorescence microscopy 
(TPLSM) image of the rhod-2-loaded heart at the graft–host border 
zone. The heart was continuously paced by point stimulation at a 
remote site at 3 Hz. Red (rhod-2) and green (EGFP) fluorescence signals 
were superimposed. Host cardiomyocytes (red) and donor-derived 
cells (green/yellow) are apparent. The white line demarcates the posi-
tion of line-scan mode data acquisition. Scale bar: 20 μm. (b) Line-scan 
mode images of the regions in a demarcated by the blue dotted lines. 
The line scans traverse one EGFP-negative (host) cardiomyocyte and 
four EGFP-expressing (donor derived) cells. Scale bars: 20 μm horizon-
tally, 125 ms vertically. (c) Spatially integrated changes in rhod-2 and 
EGFP fluorescence for one host cardiomyocyte and one donor-derived 
cell. The fluorescence signal across the entire cell was averaged. 
AU, arbitrary units; F, fluorescence.
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donor BM cells express hematopoetic  
lineage markers 
Further evidence that the transplanted BM cells do not adopt a 
cardiomyocyte phenotype was obtained by immunohistologi-
cal analyses. At 9 days after transplantation, immune staining 
revealed that clusters of EGFP-expressing cells, irrespective of 
the transplanted donor cell type, engrafted the infarct scar or 
infarct border zone (Figure 7a, d, and g), and expressed the pan-
hematopoetic cell surface antigen CD45 (Figure 7b, e, and h), 
thereby suggesting differentiation into mature hematopoetic 
cells. Morphologically, CD45- and EGFP-double positive cells 
predominately exhibited a round shape, compatible with a hema-
topoetic phenotype (Figure 7c, f, and i). Occasionally, they had 
more elongated shapes reminiscent of the CD-45-positive fibro-
blast population recently described by Haudek et al.18 (Figure 7j 
and k). Moreover, immune staining with an anti-α-actinin anti-
body revealed that no EGFP-expressing cell exhibited sarcomeric 
structure. In contrast, sarcomeric structure was readily apparent 
in host cardiomyocytes (Figure 7l).
limitations of the tPlsM imaging system
Accurate discrimination of donor cell rhod-2 fluorescence intensi-
ties from host cell fluorescence is crucial for arriving at an unam-
biguous finding regarding the functional state of individual donor 
cell–derived, EGFP-expressing cells in situ. All of the results pre-
sented above focused on the analysis of clusters of donor-derived 
cells, where interference from host cell rhod-2 fluorescence is 
not problematic. However, it was not clear whether the TPLSM 
system had sufficient resolution on the z-axis to discriminate 
between donor and host cell rhod-2 fluorescence when imaging 
isolated donor cells closely juxtaposed to host cardiomyocytes, 
particularly given the small size of the engrafted EGFP-expressing 
BM-derived cells. Preliminary control experiments to address this 
issue entailed image analysis of a non-engrafted, rhod-2 loaded, 
isolated perfused heart. Serial optical sections were recorded at 
2.0-μm axial intervals across a bifurcated capillary during contin-
uous electrical point stimulation at a rate of 4 Hz. Action poten-
tial–induced rhod-2 transients were visible as ripple-like wave 
fronts which encompass the entire width of the field of view, even 
when the focal plane is moved into the capillary lumen (Figure 8a, 
arrows). x, Z reconstructions of the same capillary during con-
tinuous electrical stimulation confirmed the apparent presence of 
rhod-2 transients within the capillary lumen (Figure 8b, arrows). 
Identical observations were made in three more hearts. These 
findings indicate a degradation of spatial resolution at depth in 
living cardiac tissue under our imaging conditions. Measurements 
of the three-dimensional fluorescence profile of 1-μm fluorescent 
spheres following intracoronary injection into a Langendorff-per-
fused heart revealed that a marked axial, but not lateral, broad-
ening of the two-photon excitation volume underlies the decline 
of spatial resolution at depth (see Supplementary Data S1 and 
Supplementary Figure S3). Consequently, the apparent occur-
rence of rhod-2 transients within the capillary lumen (Figure 8a 
and b) reflects contamination from rhod-2 signals originating 
in cardiomyocytes both below and above the imaged capillary. 
Because we found that the axial dimension of a perfusate-filled 
capillary lumen in a Langendorff-perfused mouse heart is 
 typically 8–10 μm (measured from z-stacks taken across capillar-
ies as shown in Figure 8), we estimate that rhod-2 signals sampled 
from voxels located within at least a 5-μm axial distance from a 















Figure 7 Immune histological analyses for cd45, enhanced green 
fluorescent protein (eGFP) and α-actinin in 10-μm sections obtained 
from nontransgenic hearts at 9 days after coronary artery ligation 
and injection of (a–c) ACT-EGFP low-density mononuclear (ldM), 
(d–f) c-kitenr or (g–k) lin– c-kit+ bone marrow (BM) cells. The upper 
panels in a, d, and g show representative hematoxylin and eosin–stained 
sections of the transition zone between the surviving host myocardium 
and the infarct scar in the engrafted hearts. The lower panels show that 
the donor-derived cells (green) predominately engraft within scar tissue 
or at the infarct border zone, rather than within the viable myocardium. 
The upper panels in b, e, h, and j show representative images of CD45 
expression, the middle panels show EGFP expression, and the lower pan-
els show Hoechst nuclear staining; data is taken from the regions boxed 
in a, d, and g (panels h and j correspond to the yellow and red boxes, 
respectively, in g). Panels c, f, i, and k show the corresponding merged 
fluorescence images. Scale bar: 30 μm in a; 20 μm in b and c. (l) α-Actinin 
(red) expression, EGFP (green) expression and Hoechst nuclear staining in 
tissue sections adjacent to those shown in a, d, and g. Scale bar: 20 μm.
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from both cell types. Given this, and given the dimensions of the 
engrafted BM-derived EGFP expressing cells, the TPLSM imaging 
system cannot be used to screen for the presence of [Ca2+]i tran-
sients in isolated donor cells when they are closely juxtaposed to 
host cardiomyocytes on the z-axis.
dIscussIon
The data presented here confirm the ability of adult LDM, 
c-kitenr, and lin– c-kit+ BM cells to engraft efficiently when directly 
injected into the hearts of mice that have been subjected to acute 
coronary artery ligation. In accordance with earlier observa-
tions,6–10,16 we found that the vast preponderance of donor-derived 
cells were located in clusters throughout the infarcted tissue and 
the bordering peri-infarct zone, 9 days after artery occlusion. 
TPLSM imaging revealed that, while spontaneous or remote point 
stimulation-evoked [Ca2+]i transients were observed to occur syn-
chronously in host cardiomyocytes along the graft–host border, 
they were absent in all imaged BM-derived cell clusters, irrespec-
tive of the donor cell type. Electrical field stimulation was equally 
ineffective in triggering [Ca2+]i transients in these cells. Together, 
our results indicate that the imaged donor-derived cells within the 
infarct scar are electrically inexcitable and/or unable to raise cyto-
solic calcium transiently in response to membrane depolarization. 
This result is consistent with the complete absence of sarcomeric 
α-actinin immune reactivity, and the presence of CD45 immune 
reactivity, in the EGFP-expressing donor-derived cells.
Our data also show that the TPLSM imaging system has limits 
with regard to axial resolution. Previous calculations have pre-
dicted that two-photon fluorescence excitation (and thus emis-
sion) in tissue is confined to less than femtoliter volumes around 
the focal point of a 1.2-numerical aperture water immersion 
objective, with <1-µm resolution in the z direction.19–21 Wave-front 
aberrations caused by the refractive index structure of the speci-
men have been known to compromise three-dimensional resolu-
tion in multiphoton laser scanning fluorescence microscopy.22,23 
Both theoretical and experimental approaches have shown that 
optical aberrations induced by refractive index mismatch cause a 
gradual decline in resolution (primarily in axial resolution) when 
attempting to image at increasing depths into living biological (i.e., 
aqueous) specimens, even when water immersion objectives are 
used. In line with these observations, we found a significant axial 
broadening of the two-photon excitation volume with increasing 
distance of the focal plane from the epicardial surface of living, 
buffer-perfused mouse hearts, compromising the ability of our 
imaging system to properly discriminate donor cell derived from 
host cell–derived rhod-2 signals within an axial distance of several 
microns from the donor–host interface. Our attempts to enhance 
the axial resolution by introducing a pinhole in the detection path 
resulted in near-loss of the fluorescence signal at depth (data not 
shown), in accordance with earlier reports.24
These physical constraints of the TPLSM imaging method 
preclude its ability to discriminate the origin of rhod-2 fluo-
rescence signals in small donor cells when they are closely 
juxtaposed to host cardiomyocytes. Consequently, the system 
cannot be used to screen for the presence of functional attri-
butes in isolated EGFP-expressing BM-derived cells that are 
located within a few microns from adjacent cardiomyocytes in 
the z-axis, given their small size. It is of interest to note that a 
TPLSM-based imaging approach was used in a recent study to 
demonstrate that some donor-derived cells apparently develop 
electrical stimulation–evoked rhod-2 transients in synchrony 
with host cardiomyocytes following engraftment into infarcted 
hearts.16 However, control experiments demonstrating sufficient 
in situ z-axis spatial resolution to discriminate between signals 
originating in donor and host cells under the experimental con-
ditions employed were lacking. Given the z-axis signal deteriora-
tion reported by us and by others,22,23 it is highly possible that the 
rhod-2 transients observed in donor-derived cells in that study 
arose as a consequence of fluorescence contamination from jux-
taposed host cardiomyocytes, and does not represent intrinsic 
cardiomyogenic activity in the donor cell.
Collectively, our results are incompatible with previous stud-
ies that had suggested that engrafted BM-derived cells exhibit 
both functional and structural characteristics of cardiomyocytes 
in situ (see Introduction). The underlying basis for this discrep-
ancy is not clear. Given the simplicity of the isolation procedure, 
it is unlikely that the LDM BM cells used in this study differed 
from those in studies which reported cardiomyogenic activity.4,5 
Our flow cytometry analyses, too, revealed that the scored attri-
butes of the c-kitenr BM cells and lin– c-kit+ BM cells used in 
this study (Figure 2 and Supplementary Figure S1) appeared to 
be identical to those in the studies that reported cardiomyogenic 
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Figure 8 spatial resolution of the imaging system in living heart 
 tissue. (a) Series of X, Y scans obtained from an isolated perfused mouse 
heart loaded with rhod-2 using two-photon laser scanning fluorescence 
microscopy in nondescanned mode. Images were collected across a 
bifurcating capillary at 2-μm z-steps intervals during continuous elec-
trical point stimulation at 4 Hz. Numbers indicate imaging depth (in 
μm) in reference to the image in a. The wave length of excitation light 
was 810 nm and rhod-2 fluorescence was collected between 560 and 
650 nm. The green lines in c mark the capillary endothelium. Asterisks 
denote endothelial cell nuclei. Periodic increases in rhod-2 fluorescence 
resulting from action potential–evoked increases in cytosolic calcium 
concentration are visible as ripple-like wave fronts. Some X, Y scans reveal 
the appearance of cardiomyocyte-typical rhod-2 transients within the 
perfusate-filled capillary lumen (arrows). Scale bar: 10 μm. (b) Data sets 
shown in a were converted to a stack, and the stack was then resliced to 
obtain X, Z projections of the capillary. The red lines in the X, Y scan on 
the left indicate the X positions of the X, Z profiles shown on the right. 
The green arrows denote action potential–induced rhod-2 transients. In 
all three projections, rhod-2 transients are clearly detectable within the 
capillary lumen. Scale bars: 10 μm laterally, 5 μm axially.
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 cellular composition of donor cell populations can explain the 
discrepancies in study outcomes.
EGFP may selectively destroy a BM-derived cardiogenic pre-
cursor line; indeed, earlier studies have revealed that the protein 
could be cytotoxic.25,26 EGFP could also negatively interfere with 
cardiomyogenic activity. Alternatively, instability in EGFP fluores-
cence over time could give rise to a false negative result.8 Several 
observations argue against these explanations being valid. First, 
the surface antigen expression profile in EGFP-expressing c-kitenr 
BM cell population was identical with that in the entire, EGFP-
positive and -negative, c-kitenr population (see Supplementary 
Figure S1). Second, adult ACT-EGFP cardiomyocytes stably 
express the fluorescent protein and function normally. Third, Orlic 
et al.6 found that the percentage of engrafted BM-derived bona 
fide myocytes co-expressing EGFP and cardiomyocyte-specific 
markers was similar to that of EGFP-expressing c-kit-positive 
cells before transplantation, thereby suggesting that EGFP does 
not negatively influence the transformation of BM cells into bona 
fide cardiomyocytes. It is therefore unlikely that the reporter gene 
negatively impacted cardiomyogenic activity in our study.
On the other hand, our results are in excellent agreement with 
those of a number of earlier studies that were conducted inde-
pendently in different laboratories.8–10,27 These studies exclusively 
relied on molecular analyses to follow BM cell fate following 
transplantation (see Introduction). In this study, cross-checking 
the results of functional and immunohistological analyses pro-
vided additional strong evidence that engrafted adult LDM BM 
cells, c-kitenr BM cells, and lin– c-kit+ BM cells do not give rise to 
high levels of functionally competent cardiomyocytes following 
direct injection into hearts of mice subjected to acute myocardial 
infarction. These data suggest that any functional improvement 
seen in infarcted hearts receiving BM cell transplants, both in ani-
mal studies and clinical trials, is likely to reflect a beneficial effect 
imparted upon the surviving, pre-existing myocardium, rather 
than a direct contribution of electromechanically integrated BM-
derived de novo cardiomyocytes. Possible mechanisms that under-
lie improvement in functional outcome following direct BM cell 
transplantation into ischemically injured myocardium appear to 
involve paracrine effects, resulting in prevention of cardiomyocyte 
apoptosis,28 preservation of cardiomyocyte function,28 and induc-
tion of angiogenesis.29,30
MAterIAls And Methods
All the experiments reported in this study have been approved by the 
Institutional Review Board at the Indiana University School of Medicine.
Isolation of BM cells for intracardiac transplantation. BM was 
obtained from the tibias, femurs, and iliac crests of 6–8-week-old het-
erozygous C57BL/6-Tg(ACTB-EGFP)1Osb/J mice of either sex (Jackson 
Laboratories, Bar Harbor, ME). This transgenic mouse line (designated 
ACT-EGFP) ubiquitously expresses EGFP under the control of the chicken 
β-actin promoter and cytomegalovirus enhancer. Three different subsets of 
BM cells were collected for intracardiac transplantation:
i) Unfractionated LDM BM cells. The suspension of whole BM cells 
was overlaid with sodium metrizoate (Histopaque; Sigma, St. Louis, MI) 
solution (1.083 g/ml) and centrifuged at 740g for 25 minutes. The low-
density cells were harvested, washed, and suspended (100,000 cells in 3 μl 
phosphate-buffered saline) in preparation for intracardiac injection.
ii) c-kit-enriched (c-kitenr) BM cells: LDM BM cells were reacted with a 
biotin-conjugated anti-mouse c-kit monoclonal antibody (clone ACK-4), 
and subsequently stained with streptavidin–phycoerythrin (streptavidin–
PE) (Invitrogen, Carlsbad, CA). The ACK-4/biotin/streptavidin–PE-
labeled cells were then incubated with anti-PE magnetic immunobeads 
(Miltenyi Biotec, Auburn, CA) and separated by magnet-activated cell 
sorting into c-kit+ and c-kit– fractions. Cells expressing high levels of 
c-kit were used for intracardiac injection (c-kitenr group).
iii) Lineage-depleted BM cells expressing high numbers of c-kit 
receptors (lin– c-kit+ cells). LDM BM cells were incubated with a mixture 
of rat monoclonal antibodies directed against the following murine 
hematopoetic cell lineage–specific surface markers: B lymphocytes (B220), 
T lymphocytes (CD4 and CD8), granulocytes (Gr-1), myelomonocyic cells 
(Mac-1), and erythroid cells (Ter-119) (Pharmingen, San Diego, CA).15 
Antibody-labeled lin+ cells were depleted using magnetic immunobeads 
(Miltenyi Biotec). The lineage-depleted cell population was then collected 
and incubated with a PE-conjugated anti-c-kit monoclonal antibody 
(clone ACK-4; Cedarlane Laboratories, Burlington, NC). Stained cells 
were sorted using a Becton-Dickonson cell sorter (Becton-Dickinson, 
Franklin Lakes, NJ), based on the number of c-kit receptors and levels of 
EGFP expression. Lin– cells expressing high levels of both c-kit and EGFP 
were used for intracardiac transplantation (lin– c-kit+ group).
Flow cytometry analyses of c-kitenr BM cells. In a separate set of experi-
ments, we determined the expression levels of various markers on the sur-
faces of ACT-EGFP c-kitenr BM cells using flow cytometry. c-kitenr BM cells 
were collected from heterozygous ACT-EGFP mice as described above. 
Because eluted cells were already reacted with CD117 that was developed 
by a PE-conjugated second step reagent, aliquots of these cells were stained 
with other markers for analysis, including PE-Cy5-conjugated sca-1, 
flk-1 allophycocyanin, a cocktail of allophycocyanin-conjugated lineage 
markers (CD3e, CD11b, CD45R/B220, Gr-1, and TER119), and bioti-
nylated CD34 that was further developed with streptavidin-conjugated 
 allophycocyanin-Cy7. Each aliquot was subsequently analyzed using flow 
cytometry to determine expression levels of these surface markers in the 
c-kitenr cell population.
Coronary artery ligation and intracardiac grafting. Ten- to twelve-
week-old, nontransgenic C57BL/6 mice were endotracheally intubated and 
ventilated with a rodent ventilator (Harvard Apparatus, Holliston, MA). 
Anesthesia was maintained with inhalational isoflurane. A thoracotomy 
was performed and an 8-0 polypropylene ligature was placed around the 
distal left anterior descending coronary artery as described earlier.10 Donor 
cells (100,000) suspended in 3 μl phosphate-buffered saline were injected 
into the anterior and posterior infarct border zones of the ischemic myo-
cardium 3–5 hours after coronary ligation. The chest was closed and the 
animals were weaned from the ventilator and extubated. 
Imaging of intracellular calcium transients using TPLSM. Imaging of 
intracellular calcium ([Ca2+]i) transients in Langendorff-perfused hearts 
was performed as described earlier.11,12 The hearts of all the mice were sub-
jected to TPLSM imaging at 9 or 10 days after intracardiac delivery of BM 
cells. Calcium responses in donor-derived cells and host cardiomyocytes 
were monitored during spontaneous sinus rhythm, electrical point stimu-
lation at a site remote from the graft, and electrical field stimulation. For 
a more detailed description of the imaging approach see Supplementary 
Data S1.
Immunohistochemistry. The animals were killed and the hearts were 
removed 9 days after intracardiac injection of BM cells, washed in 
 phosphate-buffered saline, immersed in fixation solution (1% paraformal-
dehyde and 1% cacodylic acid in phosphate-buffered saline) for 48 hours 
at 2–4 °C, cryoprotected in 30% sucrose, and frozen in optimum cutting 
temperature compound. Ten-micrometer cryosections were obtained and 
stained for EGFP alone (rabbit anti-EGFP; Millipore, Billerica, MA) and 
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developed with diaminobenzidine, or were stained with an anti-CD45 
 primary antibody (rat anti-CD45; Pharmingen, San Diego, CA), visualized 
with an Alexa555-conjugated secondary antibody (Invitrogen, Carlsbad, 
CA) in combination with a fluorescein isothiocyanate–conjugated goat 
anti-GFP antibody (Novus Biologicals, Littleton, CO), and nuclear 
stained with 4,6-diamidino-2-phenylindole dihydrochloride (Invitrogen, 
Carlsbad, CA). Tissue α-actinin immune reactivity was detected with a 
mouse monoclonal antibody (Sigma, St. Louis, MI) and visualized using 
a rhodamine-conjugated secondary antibody (Millipore, Billerica, MA). 
Hematoxylin and eosin and sirius red/fast green stainings were carried 
out as described earlier.31
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Figure S1. Expression levels of different surface markers in ACT-EGFP 
c-kitenr cells expressing EGFP.
Figure S2. Differentiation of cellular autofluorescence from EGFP 
 fluorescence in the infarct border zone.
Figure S3. Degradation of axial discrimination at depth in buffer-
 perfused mouse heart.
Data S1. Additional methods.
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